EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Development of the Curcumin Analog CA7 Liposome and Its Evaluation for Efficacy Against Cervical Cancer in vitro and in vivo

Linjin Xiong, Yumeng Wei, Hui Si, Zheng Li iD, Jie Wen, Furong Liu, Xiaodong Wang, Hongru Yang, Ligang Chen, Chao Pi, Yunwei Han iD, Ling Zhao

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s493074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Linjin Xiong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Electrophysiology, Ministry of Education, School of Pharmacy of Southwest Medical University, Luzhou, 646000, People's Repu…. Hauptthemen laut MEDLINE: Liposomes, Uterine Cervical Neoplasms, Curcumin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study was to develop liposomes (LP) containing a curcumin (CU) analog CA7 to enhance its pharmacokinetic profile and anti-cervical cancer (CC) effects.

Methods

Single-factor and Box-Behnken experiments were conducted to optimize the formulation of CA7-loaded liposomes (CA7-LP). The in vitro release, stability, biocompatibility, and pharmacokinetic of CA7-LP were evaluated. The biological effects of CA7-LP on Hela cells were assessed using MTT assays, colony formation assays, wound healing assays, and flow cytometry. Additionally, the anti-CC efficacy of CA7-LP was tested in mouse models of transplanted tumors.

Results

The optimal formulation of CA7-LP exhibited a particle size of 92.43 ± 1.52 nm, a polydispersity index of 0.27 ± 0.01, an encapsulation efficiency of 97.79 ± 1.49%, a drug loading of 3.23 ± 0.20%, and a zeta potential of -6.69 ± 0.77 mV. Transmission electron microscopy confirmed that a spherical morphology was exhibited by CA7-LP. The cumulative in vitro release of CA7-LP was found to be 2.84 times greater than that of CA7, and stability at room temperature was maintained for at least 90 d. Furthermore, a significantly higher uptake of CA7-LP by Hela cells was observed compared to curcumin and CA7, leading to enhanced inhibition of cell proliferation, migration and cell cycle, as well as increased apoptosis (p < 0.05). In vivo studies revealed that CA7-LP exhibited superior pharmacokinetic properties compared to CA7 (AUC: 3.58-fold, Cmax: 5.65-fold, t1/2z: 1.2-fold). The anti-CC effects of CA7-LP were found to be comparable to those of Cisplatin injection, with a better safety profile.

Conclusion

The newly developed CA7-LP is considered a promising candidate for the treatment of CC, demonstrating high potential for clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesUterine Cervical NeoplasmsCurcuminAnimalsHumansHeLa CellsFemaleMiceParticle SizeAntineoplastic AgentsApoptosisMice, Inbred BALB CRats, Sprague-DawleyCell ProliferationXenograft Model Antitumor AssaysDrug Liberation

Stichwörter der Autor:innen

cervical cancercurcumin analog CA7helaliposome

Substanzen

LiposomesCurcuminAntineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of Medical Electrophysiology, Ministry of Education, School of Pharmacy of Southwest Medical University, Luzhou, 646000, People's Republic of China.
  • Department of Psychiatry, Fundamental and Clinical Research on Mental Disorders Key Laboratory of Luzhou, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.
  • Central Nervous System Drug Key Laboratory of Sichuan Province, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.
  • Luzhou Key Laboratory of Traditional Chinese Medicine for Chronic Diseases Jointly Built by Sichuan and Chongqing, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, 646…
  • Department of Oncology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.
  • Department of Hepatobiliary Diseases, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.

ORCID-Profile: Zheng Li, Yunwei Han

Zitieren

APA

Xiong, L., Wei, Y., Si, H., Li, Z., Wen, J., Liu, F., Wang, X., Yang, H., Chen, L., Pi, C., Han, Y., & Zhao, L. (2024). Development of the Curcumin Analog CA7 Liposome and Its Evaluation for Efficacy Against Cervical Cancer in vitro and in vivo. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s493074

Vancouver

Xiong L, Wei Y, Si H, Li Z, Wen J, Liu F, et al. Development of the Curcumin Analog CA7 Liposome and Its Evaluation for Efficacy Against Cervical Cancer in vitro and in vivo. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s493074

BibTeX
@article{Xiong2024,
  author = {Xiong, Linjin and Wei, Yumeng and Si, Hui and Li, Zheng and Wen, Jie and Liu, Furong and Wang, Xiaodong and Yang, Hongru and Chen, Ligang and Pi, Chao and Han, Yunwei and Zhao, Ling},
  title = {Development of the Curcumin Analog CA7 Liposome and Its Evaluation for Efficacy Against Cervical Cancer in vitro and in vivo},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s493074}
}
Kostenlos starten →